Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy

Completed

Conditions studied: Malignant Neoplasm, Unspecified Adult Solid Tumor, Protocol Specific

In brief

This pilot clinical trial studies cognitive assessments in patients with cancer undergoing chemotherapy. Questionnaires that measure cognitive changes during chemotherapy may help identify the side effects of chemotherapy.

Key facts

Study ID

NCT01506440

Run by

Wake Forest University Health Sciences

People needed

29

Starts

2011-10-01

Expected to finish

2012-10-01

Last updated by the study team

2018-07-03

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have histologically or cytologically confirmed cancer
• Patients are candidates for systemic chemotherapy for their cancer diagnosis
• Life expectancy must be greater than 6 months
• Ability to understand and the willingness to sign a written informed consent document

You may not qualify if…

• Patients who have had prior systemic chemotherapy in their lifetime
• Patients with known brain metastases should be excluded from this clinical trial because they often develop progressive neurologic dysfunction that would confound the evaluation of neurologic and other adverse events
• Patients may not be participating on any other study investigating cognitive function
• Patients who are non-English speaking are ineligible
• Patients with hematologic malignancies are ineligible
• Patients with primary central nervous system malignancies are ineligible

Where it is running

• Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.